Growing regulatory approvals, growing biologics pipelines, and escalating financial commitment in subsequent-era peptide modalities continue on to make 2025 a pivotal growth yr for the field.The global Peptide CDMO marketplace continues to scale speedily in 2025, driven by growing expenditure in peptide-dependent therapeutics, Highly developed biol